What is Ultravist® (iopromide) used for?
Ultravist® is given as an injection in intra-arterial procedures and intravenous procedures.
How should I take Ultravist® (iopromide)?
Ultravist® will be given as an injection by your health care provider.
How do I store Ultravist® (iopromide)?
Ultravist® is best stored at room temperature away from direct light and moisture. To prevent drug damage, you should not store Ultravist® in the bathroom or the freezer. There may be different brands of Ultravist® that may have different storage needs. It is important to always check the product package for instructions on storage, or ask your pharmacist. For safety, you should keep all medicines away from children and pets.
You should not flush Ultravist® down the toilet or pour them into a drain unless instructed to do so. It is important to properly discard this product when it is expired or no longer needed. Consult your pharmacist for more details about how to safely discard your product.
Precautions & warnings
What should I know before using Ultravist® (iopromide)?
When using this drug, tell your doctor if you have:
- Anaphylactoid reactions
- Contrast induced acute kidney injury
- Cardiovascular reactions
- Thromboembolic complications
- Reactions in patients with hyperthyroidism, pheochromocytoma, or sickle cell disease
- Increased radiation exposure
- Interference with image interpretation
Is it safe during pregnancy or breastfeeding?
There are no adequate studies in women for determining risk when using Ultravist® during pregnancy or while breastfeeding. Please always consult with your doctor to weigh the potential benefits and risks before taking Ultravist®. Ultravist® is pregnancy risk category B, according to the US Food and Drug Administration (FDA).
FDA pregnancy risk category reference below:
- A=No risk
- B=No risk in some studies
- C=There may be some risk
- D=Positive evidence of risk
What side effects can occur from Ultravist® (iopromide)?
The common side effects are:
- Discoloration of the skin
- Feeling of pressure
- Warmth at the injection site
- Chest pain
- Feeling faint, dizzy, or lightheadedness
- Feeling of warmth or heat
- Flushing or redness of the skin, especially on the face and neck
- Frequent strong or increased urge to urinate
Some rare side effects include:
- Bloating or swelling of the face, arms, hands, lower legs, or feet
- Bluish lips or skin
- Chest discomfort or tightness
- Decreased frequency or amount of urination
- Difficult or painful urination
- Difficulty breathing
- Excessive thirst
- Fever or chills
- Nausea or vomiting
- Noisy breathing
- Pain or discomfort in the arms, jaw, back, or neck
- Pale skin at injection site
- Irregular heartbeat
- Tingling of the hands or feet
- Unusual tiredness or weakness
- Unusual weight gain or loss
Not everyone experiences these side effects. There may be some side effects not listed above. If you have any concerns about a side-effect, please consult your doctor or pharmacist.
What drugs may interact with Ultravist® (iopromide)?
Ultravist® may interact with other drugs that you are currently taking, which can change how your drug works or increase your risk for serious side effects. To avoid any potential drug interactions, you should keep a list of all the drugs you are using (including prescription drugs, nonprescription drugs, and herbal products) and share it with your doctor and pharmacist. For your safety, do not start, stop, or change the dosage of any drugs without your doctor’s approval.
Does food or alcohol interact with Ultravist® (iopromide)?
Ultravist® may interact with food or alcohol by altering the way the drug works or increase the risk for serious side effects. Please discuss with your doctor or pharmacist any potential food or alcohol interactions before using this drug.
What health conditions may interact with Ultravist® (iopromide)?
Ultravist® may interact with your health condition. This interaction may worsen your health condition or alter the way the drug works. It is important to always let your doctor and pharmacist know all the health conditions you currently have.
The information provided is not a substitute for any medical advice. You should ALWAYS consult with your doctor or pharmacist before using Ultravist® (iopromide).
What is the dose of Ultravist® (iopromide) for an adult?
- 300 mg I/ml for cerebral arteriography and peripheral arteriography.
- 370 mg I/ml for coronary arteriography and left ventriculography, visceral angiography, and aortography.
- 240 mg I/ml for peripheral venography
- 300 mg I/ml for excretory urography
- 300 mg I/ml and 370 mg I/ml for contrast Computed Tomography (CT) of the head and body (intrathoracic, intra-abdominal and retroperitoneal regions) for the evaluation of neoplastic and non-neoplastic lesions.
What is the dose of Ultravist® (iopromide) for a child?
The recommended dose in children over 2 years of age for the following evaluations is:
The recommended dose is injected 1 to 2 milliliters per kilogram (ml/kg). Do not exceed 4 ml/kg as total dose.
The recommended dose is injected 1 to 2 ml/kg. Do not exceed 3 ml/kg as total dose.
How is Ultravist® (iopromide) available?
Ultravist® is available in the following dosage forms and strengths:
- Ultravist® 240: Ịnjection 0,5 g/ml: Bottle 20 ml, 50 ml, 100 ml, 200 ml
- Ultravist® 300: Ịnjection 0,62 g/ml; Bottle 20 ml, 50 ml, 75 ml, 100 ml, 150 ml, 200 ml
- Ultravist® 370: Injection 0,77 g/ml: Bottle 100 ml, 150 ml, 200 ml
What should I do in case of an emergency or overdose?
In case of an emergency or an overdose, call your local emergency services or go to your nearest emergency room.
What should I do if I miss a dose?
If you miss a dose of Ultravist®, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and take your regular dose as scheduled. Do not take a double dose.
Hello Health Group does not provide medical advice, diagnosis or treatment.
Ultravist® (iopromide). https://www.drugs.com/mmx/Ultravist-300.html. Accessed November 13, 2016
Ultravist® (iopromide). https://www.drugs.com/pro/ultravist-injection.html. Accessed November 13, 2016
Review Date: February 6, 2017 | Last Modified: February 6, 2017